Anti-angiogenesis in cancer therapeutics: the magic bullet.

Ayodipupo Sikiru OguntadeFaez Al-AmodiAbdullah AlrumayhMuath AlobaidaMwango Bwalya

Published in: Journal of the Egyptian National Cancer Institute (2021)

Clinical surveillance is important for the early detection of tumour resistance and treatment failure using reliable biomarkers. It is hoped that the recent interest in mesenchymal cell-based and exosome-based nanoparticle delivery platforms will improve the cellular delivery of newer anti-angiogenics in cancer therapeutics.

Keyphrases

papillary thyroid
squamous cell
stem cells
public health
bone marrow
replacement therapy